Dapiglutide for the Treatment of Obesity

NCT05788601 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Inflammation

Interventions

DRUG: Dapiglutide
DRUG: Placebo

Sponsor

University Hospital, Gentofte, Copenhagen

Collaborators

[object Object]